goralatide has been researched along with Pericardial Effusion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badri, M; Matthews, K; Mayosi, BM; Ntsekhe, M; Sturrock, ED; Wilkinson, KA; Wilkinson, RJ; Wolske, J | 1 |
1 other study(ies) available for goralatide and Pericardial Effusion
Article | Year |
---|---|
Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction.
Topics: Case-Control Studies; Galectin 3; Humans; Oligopeptides; Pericardial Effusion; Pericarditis, Tuberculous; Pilot Projects | 2012 |